Israel Englander Enlivex Therapeutics Ltd. Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Millennium Management LLC holds 612,200 shares of ENLV stock, worth $961,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
612,200
Previous 669,008
8.49%
Holding current value
$961,154
Previous $648,000
5.71%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ENLV
# of Institutions
25Shares Held
2.57MCall Options Held
79.1KPut Options Held
0-
Armistice Capital, LLC New York, NY1.41MShares$2.22 Million0.03% of portfolio
-
Morgan Stanley New York, NY219KShares$344,0630.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny168KShares$264,3750.0% of portfolio
-
Jane Street Group, LLC New York, NY61.1KShares$95,8510.0% of portfolio
-
Sigma Investment Counselors Inc28KShares$43,9600.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $28.9M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...